Blue Origin’s Reusable Booster Succeeds, Payload Is Lost
THE UNITED ARAB EMIRATES HAS INITIATED DISCUSSIONS WITH THE U.S. ABOUT SECURING A FINANCIAL SAFETY...
AI Startup Cursor Seeks $2 Billion Funding at $50 Billion Valuation
Eli Lilly Nears Deal for Cancer Biotech
TRUMP SAID U.S. FORCES NOW HAVE FULL CUSTODY OF THE SANCTIONED VESSEL AND ITS CREW, WITH...
DONALD TRUMP CLAIMED A U.S. NAVY DESTROYER INTERCEPTED AN IRANIAN-FLAGGED CARGO SHIP “TOUSKA” IN...
India Cancels Plan to Place Biometric App on Smartphones
Global Brands See Revival in China as Retail Nationalism Cools
Trump Tweets Classified Information on US Marines and Iran Negotiations
Piper Sandler Maintains Overweight Rating on Boston Scientific Corp
TD Cowen Upgrades Tempus AI Inc to Buy Rating
Recursion Pharmaceuticals Expands Partnership with Citeline to Enhance Drug Discovery
Veeva Systems Receives Positive Outlook from Analysts
FRENCH SHIPPING FIRM CMA CGM: CONFIRMS ONE OF ITS SHIPS CAME UNDER FIRE IN THE STRAIT OF HORMUZ ON...
CANADIAN PM MARK CARNEY: SEVERAL OF OUR PREVIOUS ADVANTAGES, ROOTED IN OUR CLOSE BONDS WITH...
Hedge Fund Pay Spirals Even Higher in New Trader-Poaching Strategy
UAE in Talks With US for Possible Financial Lifeline, WSJ Says
IRANIAN SOURCE TO AL JAZEERA: GIVEN TRUMP'S REMARKS ABOUT CONDUCTING TALKS AND THE CONTRADICTION...
China's Loan Prime Rate Remains Steady Amid Shift in Monetary Policy
AWS Launches Amazon Bio Discovery to Speed AI Drug Development
A LATEST NBC SURVEY REVEALS DONALD TRUMP'S APPROVAL RATING AT A SECOND-TERM LOW, WITH 37% IN FAVOUR...
DURING THE HIGH-STAKES OPERATION TO RETRIEVE A FALLEN U.S. PILOT, ADVISERS EXCLUDED TRUMP FROM LIVE...
Top Dividend Stocks to Consider for Investment
Young Woman Achieves $100,000 in Retirement Savings by Age 25
TRUMP RESPONDED FURIOUSLY AFTER A U.S. AIRCRAFT WAS DOWNED IN IRAN, AT ONE POINT SHOUTING AT STAFF A...
Biogen Expands Targeted Therapy Pipeline Through Apellis Acquisition and Alloy Collaboration
Intel Launches Affordable Core Series 3 Processors to Enhance AI Capabilities in PCs
PAKISTAN'S PM SHARIF: CONVEYED PERSPECTIVES TO IRAN'S PEZESHKIAN FROM LATEST DISCUSSIONS WITH...
UKRAINE'S PM: IMF CONCURRED THAT HIKING TAXES ON SMALL ENTERPRISES IS NOT PRODUCTIVE....
QXO strikes $17 billion deal to acquire building products distributor and installer TopBuild
U.S. fires at, takes custody of Iranian cargo ship - Trump
UKRAINE'S PM: ADMINISTRATION WILL EXPLORE OTHER OPTIONS....
PAKISTAN PRIME MINISTER SHARIF: ASSURED IRAN'S PEZESHKIAN THAT PAKISTAN REMAINS FULLY COMMITTED AS...
Strait of Hormuz Reclosed Amid Rising Tensions Between Iran and the US
PAKISTAN'S PM SHARIF: HAD A PRODUCTIVE TALK WITH IRAN'S PRESIDENT PEZESHKIAN TONIGHT ON THE...
Occupation forces raid the town of Kafr Aqab and the vicinity of Qalandia camp north of occupied...
Traders Brace for Renewed Turmoil on Hormuz Standoff
Pakistani Prime Minister: I affirmed to Pezeshkian our full commitment to the role of mediator in...
Pakistani Prime Minister's Office: Shehbaz Sharif held a phone call with the Iranian President...
Chevron Faces Legal Challenges Amid Venezuelan Political Changes
Freeport-McMoRan Anticipates Significant Earnings Growth in Q1 2026
US Military Seizes Iranian Vessel in Gulf of Oman
Qatar Chamber organises training on ‘Legal Aspects Amid Economic Changes’
ADNOC CEO AL JABER SAYS ON X: HORMUZ BELONGS TO THE WORLD. IT MUST BE RETURNED TO THE WORLD....
ADNOC CEO AL JABER SAYS ON X: THE GLOBAL ECONOMY CANNOT AFFORD MORE UNCERTAINTY; HORMUZ STRAIT...
MAGNITUDE 6.1 EARTHQUAKE STRIKES HIHIFO, TONGA REGION - USGS...
United Airlines Set to Reveal Expansion Plans in Upcoming Earnings Report
EOG Resources Price Target Reduced by Citi Analyst
Jim Cramer Predicts Disappointing Earnings for GE Aerospace
Analysts Highlight Pricing Pressures on Pfizer's Key Products
Recent analysis has identified significant competitive and pricing pressures affecting Pfizer's major products, including Paxlovid, Vyndamax, and Prevnar. These challenges come alongside a decline in visibility for the company's COVID-19 vaccine franchise, raising concerns about the execution of its pipeline.
Pfizer is actively working to reshape its portfolio through strategic acquisitions, expansion of its product pipeline, and cost-saving initiatives. However, these efforts are complicated by the pressures on its existing products, leading to questions about dividend sustainability and the company's long-term innovation goals.
Source: KLEA News